微信直播

ITMIG 2015|Frank Detterbeck:罕见疾病研究更需关注亚组群体

Published at: 2015年第1卷第S1期

黎少灵
关键词:

编者按:第 6 届国际胸腺肿瘤协会年会(ITMIG 2015)于 2015 年 10 月 25 日在上海落下帷幕。为期 2 天的会议云集了国内外胸外科大咖。此次 ITMIG 年会是有史以来参会的会员最多,规模最大,评价最高的一次。

会后,我们有幸邀请到 ITMIG 前任主席、ITMIG 现任委员会成员、耶鲁大学医院的 Frank Detterbeck 教授跟我们分享胸腺瘤研究及胸腺手术的进展。详情请观看采访视频。

Frank Detterbeck 教授致力于循证医学研究以及多学科团队建设,一直活跃于临床科研和学术活动。目前,Detterbeck 教授已经发表过 150 多篇文章以及书稿,并在多个国际胸外科协会承担着重要职务。Detterbeck 教授在临床上专注于领域为肺癌、肺转移瘤、食管癌、胸腺瘤、纵隔肿瘤、胸壁瘤、肺上沟瘤、胸膜瘤以及肉瘤的外科治疗,研究主要围绕着肿瘤生物学、肿瘤影像技术、肿瘤预后标记物、多学科治疗和循证医学。

为了提供一个直观的胸腺手术学习和分享平台,Frank Detterbeck 教授、Robert Korst 教授和方文涛教授将在 AME 旗下 JOVS 杂志组织一期聚焦胸腺手术视频的专刊。更多信息请留意「AME科研时间」微信公众号和杂志网站(www.jovs.org)。

采访问题

  1. What is the take home message from your Innovative Lecture on Outlier Analysis?

  2. What do you think of the efficacy of subtotal and total thymectomy?

  3. How is the updated IASLC (proposal) and WHO tumor classification going to influence the upcoming study of thymic surgery?

  4. In terms of thymic surgery, which is your preferred procedure: open, VATS or robotic surgery?

  5. How would you comment on the recent development of thymic surgery in China?

 

专家介绍

 

Frank Detterbeck, MD, FACS, FCCP is a Professor of Surgery and Chief of Thoracic Surgery at Yale University and Associate Director of the Yale Cancer Center. He earned a BS in Cell Biology at the University of Michigan, and an MD degree from Northwestern University. After completing general surgery training at the Virginia Mason Clinic in Seattle, he pursued a cardiothoracic fellowship and a fellowship in thoracic transplantation at the University of North Carolina at Chapel Hill. He rose to the rank of professor of surgery at the University of North Carolina during a long tenure there before being recruited to Yale University in 2005. The major focus of his career has been on thoracic oncology. In particular, he has promoted evidence-based care and multidisciplinary teamwork. He has written extensively on these and other topics, with over 150 papers and book chapters. He holds leadership positions in many of the major professional societies associated with thoracic surgery and has given invited lectures on a wide variety of topics at many institutions and international meetings.

 

He specializes in the surgical treatment of lung cancer, lung metastases, esophageal cancer, thymoma, mediastinal tumors, chest wall tumors, Pancoast tumors, mesothelioma, and sarcoma. The majority of his thoracic/chest surgeries are performed using minimally invasive techniques. His clinical research includes cancer biology, cancer imaging techniques, prognostic markers of cancers, multimodality (multiple therapies for) treatment of cancer, and evidence-based medicine.

 

采访编辑|黎少灵,AME出版社。

视频编辑|施云彪,AME出版社。

 

ITMIG 2015 专题报道

doi:

10.3978/kysj.2014.1.1389
comments powered by Disqus

附件